For patients with RAR ≥ 7.18, it is recommended to intensify monitoring and initiate early intervention, such as optimizing nutritional support (e.g., albumin supplementation), controlling inflammatory responses (e.g., rational use of glucocorticoids), and correcting anemia. Here, ALB is linked to anemia.